Patent · US Active

Diarylhydantoin compounds

US7709517B2 · kind B2 · utility

48Cited by
48References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 15, 2006
Grant dateMay 4, 2010
Priority date
Expiry dateDec 28, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.